Share of the population living with HIV receiving antiretroviral therapy in Kazakhstan

Kazakhstan: Share of the population living with HIV receiving antiretroviral therapy was 74.0% in 2024. ◆ Volatile

Latest (2024)
74.0%
Change on year
up 5.4%
World rank
70th
of 149 countries
All-time high
74.0%
in 2024
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Kazakhstan, 1990–2024

0204060801990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 0 %1997: 0 %1998: 0 %1999: 0 %2000: 0.041 %2001: 0.123 %2002: 0.169 %2003: 0.271 %2004: 0.251 %2005: 2.6 %2006: 3 %2007: 3.8 %2008: 4.7 %2009: 6.5 %2010: 8 %2011: 10.3 %2012: 13.5 %2013: 16.5 %2014: 19.6 %2015: 24.3 %2016: 28.4 %2017: 37.8 %2018: 46.5 %2019: 51.5 %2020: 56.1 %2021: 60.2 %2022: 65.2 %2023: 70.2 %2024: 74 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

The most recent figure for share of the population living with hiv receiving antiretroviral therapy in Kazakhstan is 74.0%, measured in 2024. That is the highest value across all 35 years on record.

That represents a change of up 5.4% on the previous year and up 277.2% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Kazakhstan peaked at 74.0% in 2024 and was at its lowest, 0.0%, in 1990.

That places Kazakhstan 70th out of 149 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Kazakhstan, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Kazakhstan, 1990 to 2024.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1996 0.0% —
1997 0.0% —
1998 0.0% —
1999 0.0% —
2000 0.0% —
2001 0.1% +197.0%
2002 0.2% +36.9%
2003 0.3% +60.8%
2004 0.3% -7.2%
2005 2.6% +936.5%
2006 3.0% +16.5%
2007 3.8% +26.1%
2008 4.7% +22.3%
2009 6.5% +39.6%
2010 8.0% +22.1%
2011 10.3% +29.1%
2012 13.5% +30.9%
2013 16.5% +22.7%
2014 19.6% +18.7%
2015 24.3% +23.8%
2016 28.4% +16.9%
2017 37.8% +33.1%
2018 46.5% +23.0%
2019 51.5% +10.7%
2020 56.1% +8.9%
2021 60.2% +7.4%
2022 65.2% +8.3%
2023 70.2% +7.7%
2024 74.0% +5.4%

Kazakhstan compared with similar countries

  • Kazakhstan's 74.0% is above the median for upper middle income countries, which is 65.5%, 1.1× the median. (43 countries reporting)
  • Kazakhstan's 74.0% is below the median for Europe & Central Asia, which is 82.9%, 89% of the median. (34 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in Kazakhstan changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +936.5% 0.3% 2.6%
2001 +197.0% 0.0% 0.1%

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.0% 0.0% 0.0% 10
2000s 2.2% 0.0% 6.5% 10
2010s 25.6% 8.0% 51.5% 10
2020s 65.2% 56.1% 74.0% 5

Countries ranked near Kazakhstan

  1. 67 Bahamas 74.4% compare
  2. 68 Honduras 74.2% compare
  3. 69 Vietnam 74.1% compare
  4. 71 Antigua and Barbuda 73.1% compare
  5. 72 Brazil 72.7% compare
  6. 73 Georgia 71.9% compare

See the full ranking of 149 places →

More reference data data for Kazakhstan

All data for Kazakhstan →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Kazakhstan?
Share of the population living with hiv receiving antiretroviral therapy in Kazakhstan was 74.0% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Kazakhstan?
The highest recorded value was 74.0% in 2024.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Kazakhstan?
The lowest recorded value was 0.0% in 1990.
How does Kazakhstan rank for share of the population living with hiv receiving antiretroviral therapy?
Kazakhstan ranks 70th out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Kazakhstan?
Over the last ten years it is up 277.2%. The long-run trend across the full record is volatile.
Where does this Kazakhstan data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Kazakhstan. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/kazakhstan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/kazakhstan/">Share of the population living with HIV receiving antiretroviral therapy in Kazakhstan</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.